|
Sanara MedTech Inc. (SMTI) Évaluation DCF
US | Healthcare | Medical - Instruments & Supplies | NASDAQ
|
- ✓ Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
- ✓ Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
- ✓ Pré-Construits Pour Une Utilisation Rapide Et Efficace
- ✓ Aucune Expertise N'Est Requise; Facile À Suivre
Sanara MedTech Inc. (SMTI) Bundle
Que vous soyez un investisseur ou un analyste, cette calculatrice DCF (SMTI) sert de votre outil essentiel pour une évaluation précise. Chargé de données réelles de Sanara MedTech Inc., vous pouvez ajuster les prévisions et observer immédiatement les effets.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 11.8 | 15.6 | 24.1 | 45.8 | 65.0 | 100.6 | 155.6 | 240.8 | 372.7 | 576.8 |
| Revenue Growth, % | 0 | 32.47 | 54.9 | 89.87 | 41.77 | 54.75 | 54.75 | 54.75 | 54.75 | 54.75 |
| EBITDA | -2.6 | -4.0 | -7.2 | -11.9 | -.3 | -21.0 | -32.4 | -50.2 | -77.7 | -120.2 |
| EBITDA, % | -22.18 | -25.82 | -29.91 | -25.85 | -0.44483 | -20.84 | -20.84 | -20.84 | -20.84 | -20.84 |
| Depreciation | .1 | .4 | .8 | 2.6 | 3.7 | 3.7 | 5.7 | 8.8 | 13.6 | 21.0 |
| Depreciation, % | 1.02 | 2.62 | 3.2 | 5.75 | 5.65 | 3.65 | 3.65 | 3.65 | 3.65 | 3.65 |
| EBIT | -2.7 | -4.4 | -8.0 | -14.5 | -4.0 | -24.6 | -38.1 | -59.0 | -91.3 | -141.3 |
| EBIT, % | -23.2 | -28.44 | -33.11 | -31.6 | -6.1 | -24.49 | -24.49 | -24.49 | -24.49 | -24.49 |
| Total Cash | 6.6 | .5 | 18.7 | 9.0 | 5.1 | 33.0 | 51.0 | 78.9 | 122.1 | 189.0 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 1.3 | 2.3 | 3.0 | 7.0 | 8.5 | 13.4 | 20.8 | 32.1 | 49.7 | 76.9 |
| Account Receivables, % | 11.35 | 14.54 | 12.38 | 15.28 | 13.13 | 13.34 | 13.34 | 13.34 | 13.34 | 13.34 |
| Inventories | .7 | 1.1 | 2.0 | 3.5 | 4.7 | 7.5 | 11.6 | 17.9 | 27.7 | 42.9 |
| Inventories, % | 6.34 | 7.37 | 8.48 | 7.74 | 7.26 | 7.44 | 7.44 | 7.44 | 7.44 | 7.44 |
| Accounts Payable | .3 | .5 | .6 | 1.4 | 2.0 | 3.0 | 4.6 | 7.1 | 11.0 | 17.0 |
| Accounts Payable, % | 2.87 | 3.17 | 2.46 | 3.11 | 3.08 | 2.94 | 2.94 | 2.94 | 2.94 | 2.94 |
| Capital Expenditure | -1.7 | -1.6 | -.8 | -.7 | -.3 | -6.1 | -9.4 | -14.5 | -22.5 | -34.8 |
| Capital Expenditure, % | -14.49 | -10.55 | -3.11 | -1.63 | -0.40813 | -6.04 | -6.04 | -6.04 | -6.04 | -6.04 |
| Tax Rate, % | 3.08 | 3.08 | 3.08 | 3.08 | 3.08 | 3.08 | 3.08 | 3.08 | 3.08 | 3.08 |
| EBITAT | -2.8 | -4.4 | -7.3 | -8.4 | -3.8 | -21.9 | -33.9 | -52.5 | -81.2 | -125.7 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -6.2 | -6.8 | -8.8 | -11.2 | -2.6 | -31.0 | -47.5 | -73.4 | -113.7 | -175.9 |
| WACC, % | 11.14 | 11.14 | 11.13 | 11.08 | 11.14 | 11.13 | 11.13 | 11.13 | 11.13 | 11.13 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -298.2 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -179 | |||||||||
| Terminal Value | -1,966 | |||||||||
| Present Terminal Value | -1,160 | |||||||||
| Enterprise Value | -1,458 | |||||||||
| Net Debt | 7 | |||||||||
| Equity Value | -1,465 | |||||||||
| Diluted Shares Outstanding, MM | 8 | |||||||||
| Equity Value Per Share | -176.93 |
What You Will Get
- Real SMTI Financial Data: Pre-filled with Sanara MedTech Inc.’s historical and projected data for precise analysis.
- Fully Editable Template: Easily modify key inputs like revenue growth, WACC, and EBITDA %.
- Automatic Calculations: Instantly see Sanara MedTech’s intrinsic value update based on your changes.
- Professional Valuation Tool: Tailored for investors, analysts, and consultants seeking accurate DCF results.
- User-Friendly Design: Clear structure and straightforward instructions suitable for all experience levels.
Key Features
- Comprehensive SMTI Data: Pre-loaded with Sanara MedTech’s historical performance metrics and future growth forecasts.
- Customizable Financial Inputs: Tailor assumptions for revenue growth, profit margins, discount rates, tax implications, and capital investments.
- Interactive Valuation Model: Automatically refreshes Net Present Value (NPV) and intrinsic value based on your specified parameters.
- Scenario Analysis: Develop various forecasting scenarios to evaluate different valuation results.
- Intuitive Interface: Designed for ease of use, suitable for both seasoned professionals and newcomers.
How It Works
- 1. Access the Template: Download and open the Excel file featuring Sanara MedTech Inc.'s (SMTI) preloaded data.
- 2. Modify Assumptions: Adjust key inputs such as growth rates, WACC, and capital expenditures.
- 3. Analyze Results Instantly: The DCF model automatically computes intrinsic value and NPV.
- 4. Explore Scenarios: Evaluate multiple forecasts to assess various valuation outcomes.
- 5. Present with Assurance: Share professional valuation insights to bolster your decision-making.
Why Choose This Calculator for Sanara MedTech Inc. (SMTI)?
- All-in-One Solution: Features DCF, WACC, and financial ratio analyses tailored for Sanara MedTech Inc. (SMTI).
- Flexible Inputs: Modify the yellow-highlighted cells to explore different financial scenarios.
- In-Depth Analysis: Automatically computes the intrinsic value and Net Present Value for Sanara MedTech Inc. (SMTI).
- Preloaded Information: Access to historical and projected data for a reliable analysis.
- Expert-Level Tool: Perfect for financial analysts, investors, and business advisors focusing on Sanara MedTech Inc. (SMTI).
Who Should Use Sanara MedTech Inc. (SMTI)?
- Healthcare Investors: Make informed investment choices with a reliable analysis of medical technology advancements.
- Medical Analysts: Streamline your research with a comprehensive framework tailored for the healthcare sector.
- Consultants: Effortlessly modify the resources for client discussions or strategic presentations.
- Healthcare Enthusiasts: Enhance your knowledge of medical innovations and their market impact through detailed insights.
- Educators and Students: Utilize it as a hands-on educational resource in healthcare and finance courses.
What the Template Contains
- Operating and Balance Sheet Data: Pre-filled Sanara MedTech Inc. (SMTI) historical data and forecasts, including revenue, EBITDA, EBIT, and capital expenditures.
- WACC Calculation: A dedicated sheet for Weighted Average Cost of Capital (WACC), including parameters like Beta, risk-free rate, and share price.
- DCF Valuation (Unlevered and Levered): Editable Discounted Cash Flow models showing intrinsic value with detailed calculations.
- Financial Statements: Pre-loaded financial statements (annual and quarterly) to support analysis.
- Key Ratios: Includes profitability, leverage, and efficiency ratios for Sanara MedTech Inc. (SMTI).
- Dashboard and Charts: Visual summary of valuation outputs and assumptions to analyze results easily.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.